Document Detail


Diabetic pulmonary microangiopathy - fact or fiction?
MedLine Citation:
PMID:  21528480     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Elevated levels of serum glucose have deleterious effects on the walls of blood vessels, leading to microangiopathy. Such a destructive process involves also pulmonary circulation, where it is referred to as diabetic pulmonary microangiopathy. This hypothesis has been confirmed in histopathologic examinations of pulmonary parenchyma, as well as in pulmonary function tests. However, so far there have been no clinical implications of these findings. Another phenomenon requiring further discussion involves diabetics with clinically silent respiratory dysfunction. That may result from significant vascular and ventilation reserves that compensate for partial loss of pulmonary parenchyma in the course of diabetes. In this review, we present an overview of the available publications on pulmonary microangiopathy and its influence on the functioning of the respiratory system. (Pol J Endocrinol 2011; 62 (2): 171-175).
Authors:
Krzysztof Kuziemski; Krzysztof Specjalski; Ewa Jassem
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Endokrynologia Polska     Volume:  62     ISSN:  0423-104X     ISO Abbreviation:  Endokrynol Pol     Publication Date:    2011 Mar-Apr
Date Detail:
Created Date:  2011-04-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370674     Medline TA:  Endokrynol Pol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  171-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alternative splicing and its role in pathologies of the endocrine system.
Next Document:  Wernicke-Korsakoff syndrome in the course of thyrotoxicosis - a case report.